Nutri Pharmaceuticals Research Inc. Reports Record First Quarter Earnings
20 Abril 2006 - 9:05AM
Business Wire
Nutri Pharmaceuticals Research Inc. (Pink Sheets: NRPR) today
reported first quarter 2005 results from operations. Sales
approximated $421,000 as compared to $290,000 in first quarter of
the prior year. Gross profit approximated $339,000 as compared to
$207,000 in same period of the prior year. Operating expenses
approximated $281,000 as compared to $179,000. Overall net income
approximated $42,000 as compared to $11,000 in the same period of
the prior year. Commenting on the results, Chief Executive Officer
and President Godfrey Yew said: "We are thrilled to have concluded
our best quarter results. Our performance this quarter reflects the
sustained momentum we generated from our business development
efforts during 2005. We have negotiated more favorable contracts
and have been able to reduce our overall operating expenses." About
NPRI Nutri Pharmaceuticals Research Inc. (www.o2p.us) provides a
wide range of powdered oils for functional food, food supplement,
dietary supplement, cosmetics, pet food and animal feed
applications. The company is one of a select few to be awarded the
prestigious Nutrition Business Journal "Product Merit Award" for
its patent-pending O2P(TM) Powderization Process. At the heart of
its oil powders is the O2P Oil-to-Powder technology. This
patent-pending process converts most edible oils, gels or pastes
into a free-flowing powder without affecting the isomeric
structure, fatty acid profile, color, taste or aroma of the base
oil. O2P does not rely on traditional techniques that utilize
extremes in heat or cold, or micro-encapsulation technology. The
company currently offers more than 50 shelf-stable powders. The
company can also apply O2P technology to a third party's oil, paste
or gel through an arrangement called tolling. Based in Las Vegas,
the company has representative sales offices near Chicago,
Amsterdam, Guatemala City and Bangkok. Nutri Pharmaceuticals
Research Inc. shares are currently traded in the United States on
the "NQB (National Quotation Bureau) Pinksheets" under the symbol
NRPR.PK. Forward-Looking Statements The words "believe," "expect,"
"anticipate" and other similar expressions generally identify
forward-looking statements. Forward-looking statements are based on
the company's current expectations and are subject to market,
competitive and regulatory factors and the other risks and
uncertainties indicated from time to time in the company's filings
with the Securities and Exchange Commission. Actual results can
differ materially. The company makes no commitment to disclose any
revisions to forward-looking statements.
Nutri Pharmaceuticals Re... (PK) (USOTC:NRPR)
Gráfico Histórico do Ativo
De Fev 2025 até Mar 2025
Nutri Pharmaceuticals Re... (PK) (USOTC:NRPR)
Gráfico Histórico do Ativo
De Mar 2024 até Mar 2025
Notícias em tempo-real sobre Nutri Pharmaceuticals Research Inc (PK) da OTCMarkets bolsa de valores: 0 artigos recentes
Mais Notícias de Nutri Pharmaceuticals Research Inc.